![Eisai Double-acting Orexin Receptor Antagonist Dayvigo (lemborexant) Is Launched In The US! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Eisai Double-acting Orexin Receptor Antagonist Dayvigo (lemborexant) Is Launched In The US! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2020524038/20200610153737b4ca2c8aeb2a4167afff819e938accf2.png)
Eisai Double-acting Orexin Receptor Antagonist Dayvigo (lemborexant) Is Launched In The US! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Frontiers | The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions Frontiers | The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions](https://www.frontiersin.org/files/Articles/36072/fendo-04-00018-HTML/image_m/fendo-04-00018-g001.jpg)
Frontiers | The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions
![Frontiers | Orexin/hypocretin system dysfunction in patients with Takotsubo syndrome: A novel pathophysiological explanation Frontiers | Orexin/hypocretin system dysfunction in patients with Takotsubo syndrome: A novel pathophysiological explanation](https://www.frontiersin.org/files/Articles/1016369/fcvm-09-1016369-HTML-r2/image_m/fcvm-09-1016369-g001.jpg)